Over half of the UK's GPs would vote Conservative, the party that also planned to address drug provision

15 January 2010

The majority of General Practitioners in the UK now favor the Conservative Party's health policy, despite opposing Tory plans to impose commissioning responsibility on the profession, according to a poll for the UK-based GP newspaper

The poll of GPs' voting intentions reveals just 15% will back Labour and only 17% prefer Labour's health policies. The survey of 314 GPs found 53% plan to vote Conservative this year, compared with just 24% in 1997. A general election is due in the UK by this summer, with May 6 mooted as the most likely date.

GPs are unhappy with many of Labour's flagship policies, with 59% condemning practice-based commissioning as a 'failure' and 78% opposed to plans to scrap practice boundaries. With the election campaign under way and focused on health, nearly 6% of GPs remain undecided as to for who they will vote. A previous GP poll found that, in 1997 the Conservatives were seen as having the worst health policy of the major parties.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical